ÂÜÀòÂÒÂ×

Karim Mark Munir is a seasoned finance executive currently serving as Vice President of Finance at Axsome Therapeutics, Inc. since October 2022. Previously, Karim held various leadership roles at Bristol-Myers Squibb from 2014 to October 2022, including Controller for U.S. Pharmaceuticals and Director of Corporate Financial Reporting and Global Consolidation, where responsibilities included SEC reporting, accounting for acquisitions, and overseeing significant financial processes for an $8 billion revenue segment. Prior experience also includes positions at Wyeth, where Karim managed external reporting and capital markets, and a foundational role in internal audit. Karim holds an MBA in Financial Management with Supply Chain from Rutgers University and a Bachelor of Arts in Accounting and Finance from Moravian University.